Twelve-Month Efficacy and Tolerability of Netarsudil 0.02% in Korean Patients with Primary Open-Angle Glaucoma and Normal-Tension Glaucoma: A Single-Center Retrospective Study.
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.